Bladder Cancer

Latest News

FDA accepts IND application for UGN-103 in NMIBC
FDA accepts IND application for UGN-103 in NMIBC

April 15th 2024

The IND will initiate the launch of a phase 3 study to explore the safety and efficacy of UGN-103 in patients with low-grade, intermediate-risk NMIBC.

Cell therapy TARA-002 shows initial promise in NMIBC
Cell therapy TARA-002 shows initial promise in NMIBC

April 9th 2024

ctDNA status selects for favorable prognosis in MIBC
ctDNA status selects for favorable prognosis in MIBC

April 9th 2024

Nadofaragene firadenovec shows durable efficacy in NMIBC
Nadofaragene firadenovec shows durable efficacy in NMIBC

April 8th 2024

Blue light cystoscopy improves NMIBC detection in all racial groups
Blue light cystoscopy improves NMIBC detection in all racial groups

March 29th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.